Clinical Trial Update: Casodex vs Placebo in Non-Metastatic Early Prostate Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Casodex to placebo in non-metastatic early prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Casodex (bicalutamide)

Snippet

Sponsor: AstraZeneca | Conditions: Non-Metastatic Prostate Cancer | Phase 3 | Status: COMPLETED